Amanote Research
Register
Sign In
Synergistic Effects of Verapamil and Anti-Mdr1 Ribozyme on Reversion of Multidrug Resistance in the P-Glycoprotein-Positive K562 Cell Line
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2402072
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
April 1, 2001
Authors
Y Gong
W Han
J Liu
F Chen
J Han
Y Jin
R Ou Yong
Publisher
Springer Science and Business Media LLC
Related search
Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Defining the Drug-Binding Site in the Human Multidrug Resistance P-Glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
PLoS ONE
Multidisciplinary
A Stronger Reversal Effect of the Combination of Dasatinib and Menadione on P-Gp-Mediated Multidrug Resistance in Human Leukemia K562/Adr Cell Line
RSC Advances
Chemistry
Chemical Engineering
P‐Glycoprotein, Multidrug Resistance and Protein Kinase C
Oncologist
Cancer Research
Medicine
Oncology
Doxorubicin Selected Multidrug-Resistant Small Cell Lung Cancer Cell Lines Characterised by Elevated Cytoplasmic Ca2+ and Resistance Modulation by Verapamil in Absence of P-Glycoprotein Overexpression
British Journal of Cancer
Cancer Research
Oncology
HIV-1 Integrase Inhibitors Are Substrates for the Multidrug Transporter MDR1-P-glycoprotein
Retrovirology
Virology
Infectious Diseases
P Glycoprotein (ABCB1; MDR1; P-Gp)
Science-Business eXchange
P Glycoprotein (MDR1; ABCB1; P-Gp; CD243)
Science-Business eXchange
